首页 | 本学科首页   官方微博 | 高级检索  
     

靶向PD-1/PD-L1放射性核素分子探针及其在恶性肿瘤中的应用
引用本文:张玉,杨梦蝶,余飞. 靶向PD-1/PD-L1放射性核素分子探针及其在恶性肿瘤中的应用[J]. 国际放射医学核医学杂志, 2022, 46(6): 374-379. DOI: 10.3760/cma.j.cn121381-202107003-00188
作者姓名:张玉  杨梦蝶  余飞
作者单位:同济大学附属第十人民医院核医学科 ,上海 200072
摘    要:程序性细胞死亡受体1(PD-1)及其配体(PD-L1)免疫治疗已成为一种治疗多种恶性肿瘤的重要方法,但仅有部分患者临床获益,其影响因素之一是恶性肿瘤PD-1/PD-L1的表达水平。使用放射性核素标记完整单克隆抗体和抗体片段等制成靶向PD-1/PD-L1放射性核素分子探针进行显像,可无创、实时、动态地监测肿瘤PD-1/PD-L1的表达并量化其表达水平,进而筛选适宜治疗的患者、全面评估治疗疗效和预后。笔者综述了靶向PD-1/PD-L1放射性核素分子探针及其在恶性肿瘤中的应用。

关 键 词:放射性核素显像   分子探针   程序性细胞死亡受体1   B7-H1抗原   肿瘤
收稿时间:2021-07-07

Targeted PD-1/PD-L1 radionuclde molecular probes and its application in malignant tumors
Yu Zhang,Mengdie Yang,Fei Yu. Targeted PD-1/PD-L1 radionuclde molecular probes and its application in malignant tumors[J]. International Journal of Radiation Medicine and Nuclear Medicine, 2022, 46(6): 374-379. DOI: 10.3760/cma.j.cn121381-202107003-00188
Authors:Yu Zhang  Mengdie Yang  Fei Yu
Affiliation:Department of Nuclear Medicine, the Tenth People's Hospital of Tongji University, Shanghai 200072, China
Abstract:Programmed cell death 1 receptor (PD-1) and its ligand (PD-L1) immunotherapy has become an important method for the treatment of a variety of malignant tumors, but only some patients have clinical benefits. One of the influencing factors is the expression level of PD-1/PD-L1 in malignant tumors. Radionuclide labeled complete monoclonal antibodies and antibody fragments are used to make targeted PD-1/PD-L1 radionuclide molecular probes for imaging, which can noninvasively, real-time, and dynamically monitor the expression of tumor PD-1/PD-L1 and quantify its expression level, so as to screen patients suitable for treatment and comprehensively evaluate the treatment efficacy and prognosis. The authors review the application of targeted PD-1/PD-L1 radionuclide molecular probes in malignant tumors.
Keywords:Radionuclide imaging  Molecular probes  Programmed cell death 1 receptor  B7-H1 antigen  Neoplasms
点击此处可从《国际放射医学核医学杂志》浏览原始摘要信息
点击此处可从《国际放射医学核医学杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号